B2M and neoplasm: We noticed that neither CD8+ T cell depletion nor B2m knockout exhibited full rescue of the tumor growth from Pikfyve-loss (SI Appendix, Fig. S4 B and D), suggesting that Pikfyve-loss may inhibit tumor growth in an immune-independent manner (30).